Kirma et al. demonstrated that cervical cancer cells produced high levels of CSF-1, and CSF-1R blockade reduced the migratory capacity of cancer cells, suggesting the involvement of CSF-1 in tumor malignancy via the autocrine receptor activation [28]. This evidence concerns the gene CSF1 and cervical cancer.